UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2015 |
Sep. 30, 2014 |
Sep. 30, 2015 |
Sep. 30, 2014 |
|
| REVENUES | ||||
| REVENUES: | $ 0 | $ 0 | $ 0 | $ 0 |
| COSTS AND EXPENSES: | ||||
| General and Administrative | 225,047 | 216,761 | 608,893 | 726,821 |
| Professional fees and Consulting expense | 343,320 | 370,865 | 1,008,128 | 643,462 |
| Research and Development | 219,938 | 508,816 | 775,511 | 1,305,627 |
| Total Costs and Expenses | 788,305 | 1,096,442 | 2,392,532 | 2,675,910 |
| LOSS FROM OPERATIONS | (788,305) | (1,096,442) | (2,392,532) | (2,675,910) |
| OTHER INCOME (EXPENSE): | ||||
| Other Income | 0 | 0 | 34,963 | 93,683 |
| Other Expense | 0 | 0 | 0 | (118,467) |
| Fair Value Adjustment of Derivative Liability | 0 | (1,475,643) | 0 | 4,481,478 |
| Amortization of Debt Discount | (450,006) | (467,671) | (1,414,975) | (1,285,295) |
| Amortization of Deferred Finance Costs | 0 | 0 | 0 | (4,835) |
| Finance Costs | (48,601) | (152,496) | (490,356) | (152,496) |
| Interest expense | (187,687) | (147,977) | (508,561) | (383,604) |
| Total Other Income (Expense) | (686,294) | (2,243,787) | (2,378,929) | 2,630,464 |
| NET LOSS | $ (1,474,599) | $ (3,340,229) | $ (4,771,461) | $ (45,446) |
| X | ||||||||||
- Definition Amortization of Debt Discount No definition available.
|
| X | ||||||||||
- Definition Fair value as of the balance sheet date of the gross assets less the gross liabilities of a derivative liability or group of derivative liabilities No definition available.
|
| X | ||||||||||
- Definition Fair value adjustment of derivative liability.. No definition available.
|
| X | ||||||||||
- Definition For an unclassified balance sheet, the carrying amount (net of accumulated amortization) as of the balance sheet date of capitalized costs associated with the issuance of debt instruments (for example, legal, accounting, underwriting, printing, and registration costs) that will be charged against earnings over the life of the debt instruments to which such costs pertain. No definition available.
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition This element represents a sum total of expenses not separately reflected on the income statement for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|